Palatin Technologies
PTN
$1.82
Share price
5.81%
Change (1 day)
-22.88%
Change (1 year)
Categories
Palatin Technologies (PTN) - Cash on Hand
Cash on Hand as of December 2023 : $9.48 M
According to Palatin Technologies's latest financial reports the company has $9.48 M in cash and cash equivalents.
A company’s cash on hand also refered as cash/cash equivalents (CCE) and Short-term investments, is the amount of accessible money a business has.
Palatin Technologies - Cash on Hand chart (from 2001 to 2023)
Cash on Hand by year
| Year | Cash on Hand | Change |
|---|---|---|
| 2023-06-30 | $10.98 M | -63.32% |
| 2022-06-30 | $29.93 M | -50.19% |
| 2021-06-30 | $60.1 M | -27.46% |
| 2020-06-30 | $82.85 M | 90.42% |
| 2019-06-30 | $43.51 M | 14.5% |
| 2018-06-30 | $38 M | -6.06% |
| 2017-06-30 | $40.45 M | 331.09% |
| 2016-06-30 | $9.38 M | -65.63% |
| 2015-06-30 | $27.29 M | 124.05% |
| 2014-06-30 | $12.18 M | -50.1% |
| 2013-06-30 | $24.41 M | 537.99% |
| 2012-06-30 | $3.82 M | -79.72% |
| 2011-06-30 | $18.86 M | 112.79% |
| 2010-06-30 | $8.86 M | 13.42% |
| 2009-06-30 | $7.81 M | -38.8% |
| 2008-06-30 | $12.77 M | -62.17% |
| 2007-06-30 | $33.77 M | 10.13% |
| 2006-06-30 | $30.66 M | 69.36% |
| 2005-06-30 | $18.1 M | -11.3% |
| 2004-06-30 | $20.41 M | 11.04% |
| 2003-06-30 | $18.38 M | 131.4% |
| 2002-06-30 | $7.94 M | -30.66% |
| 2001-06-30 | $11.45 M |
Cash on Hand for similar companies or competitors
| Company | Cash on Hand | differencediff. | Country |
|---|---|---|---|
 Johnson & Johnson JNJ | $22.92 B | 241,612.13% | 🇺🇸 USA |
 AstraZeneca AZN | $5.86 B | 61,680.13% | 🇬🇧 UK |
 Neurocrine Biosciences
NBIX | $1.03 B | 10,775.83% | 🇺🇸 USA |
 MediciNova MNOV | $50.99 M | 437.67% | 🇺🇸 USA |
 Ligand Pharmaceuticals LGND | $0.17 B | 1,695.51% | 🇺🇸 USA |
 Dicerna Pharmaceuticals DRNA | N/A | N/A | 🇺🇸 USA |
 ANI Pharmaceuticals ANIP | $0.22 B | 2,231.21% | 🇺🇸 USA |
 GlycoMimetics
GLYC | $49.4 M | 420.89% | 🇺🇸 USA |
 Ardelyx ARDX | $0.18 B | 1,843.01% | 🇺🇸 USA |